Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05741905 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Efficacy of Levofloxacin Combined With Intravenous Thrombolysis for Acute Ischemic Stroke

StatusRecruiting
PhaseNot applicable
SponsorYi Yang
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 2, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion date: Jun 1, 2024 to Dec 31, 2024
    • Study completion date: Sep 30, 2024 to Dec 31, 2024
    v5
  2. Notable Primary endpoints revised (2)v4
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Primary endpoints revised (2)
    • Study sites: 0 to 1
    • Eligibility criteria expanded, about 2 words
    v3
  4. Notable Start date: Feb 13, 2023 to Jun 1, 2023
    • Primary completion date: Feb 14, 2024 to Jun 1, 2024
    • Study completion date: May 31, 2024 to Sep 30, 2024
    • Eligibility criteria shortened, about 13 words
    v2
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
17 trials monitored
See all monitored trials
3,531 trials monitored
See 153 trials at risk
The purpose of this study is to determine the efficacy and safety of levofloxacin combined with intravenous thrombolysis in treating acute ischemic stroke
Trial Details
NCT Number NCT05741905
Lead Sponsor Yi Yang
Conditions
(from sponsor)
Acute Ischemic Stroke
Related terms Ischemic Stroke
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov